dimarts, 30 de setembre del 2014

'Frotox' maker Myoscience raises $8m




Myoscience secures $8.4 million in new funding for its 'frotox' device that applies extreme cold to the skin to temporarily treat pain and smooth wrinkles.






Myoscience said it landed $8.4 million of a hoped-for $11.5 million for a device that applies extreme cold to the skin as a way to temporarily treat pain and smooth wrinkles.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rCN6a3

What to be wary of in the government's new site detailing industry money to docs




The government's new website on drug and device company ties to doctors will be incomplete and may be misleading - for now.





What to be wary of in the government's new site detailing industry money to docs

David Sleight/ProPublica



by Charles Ornstein, ProPublica


This story was co-published with NPR's Shots blog.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rCN7ut

Activist investor erupts at Volcano




Activist investor fund Engaged Capital ups the pressure on Volcano Corp., scolding it for its $116 million AtheroMed acquisition and missing chances to sell itself at a premium.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rCtUco

FDA releases final recs on legal exemptions for customized medical devices | Regulatory news for the week of September 29, 2014




Here's a look at some of the top regulatory stories for medical device companies this week: FDA guides on custom devices; FDA approves Gore's Viabahn for peripheral stent repair; Alcon wins date with FDA panel for AcrySof lens; FDA seeks public input on medtech hacking; ReFlow Medical wins CE Mark for crossing catheters;






FDA guides on custom devices


September 25, 2014 by Alexander Soule





read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rCeJzU

In Massachusetts governor's race, the medical device tax has no friends




Candidates in the race for Massachusetts governor race tell MassDevice.com that they're for a repeal of the medical device tax and would support exploring a potential offset for Bay State medtech companies.






The next Massachusetts governor won't be spending any political capital defending the medical device tax, a 2.3% excise tax on U.S. medtech sales. Both of the leading candidates told MassDevice.com yesterday that they would push for a federal appeal and consider a tax credit to offset the levy.



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rAgzQC

dilluns, 29 de setembre del 2014

Studies criticize U.S. medical device approval process




The FDA's less-stringent 510(k) clearance process comes under fire (again) in a pair of new studies.






NEW YORK (Reuters Health) - Information on the safety and effectiveness of medical devices before and after they are cleared by U.S. health regulators can be improved, according to 2 new studies.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rFVNR1

Mitralign reports 1st-in-human tricuspid valve repair




Mitralign reports the 1st-in-human use of its minimally invasive device to treat tricuspid valve regurgitation under a compassionate use allowance in Germany.






Mitralign said today that surgeons in Germany implanted its tricuspid valve repair device in its 1st patient, under a "compassionate use" allowance in Germany.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rz0ETP

Cohealo raises $3m for medical device sharing software




Cohealo reports a $3.2 million debt round for the software it's developing to help hospitals manage their shared medical device inventory.






Cohealo reported raising $3.1 million of a hoped-for $5.8 million in debt financing as it develops software to help hospitals manage their shared medical device inventory.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uxhULv

Renal denervation: How St. Jude Medical could prevail where Medtronic failed




Despite the widespread skepticism over renal denervation for hypertension after the failure of Medtronic's Symplicity-3 trial, St. Jude Medical could be poised to snatch victory from the jaws of defeat with its next-generation EnligHTN device.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vqeusX

CVRx wins heart failure CE Mark for Barostim Neo neurostim device




CVRx adds CE Mark approval for treating heart failure patients to its European Union approval for hypertension treatment using its Barostim Neo device.






CVRx said today that it won CE Mark approval in the European Union for its Barostim Neo device to treat heart failure patients using vagus nerve stimulation.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uWIREY

What we've learned from four years of diving into dollars for docs




Payments from pharmaceutical companies touch hundreds of thousands of doctors. The 17 companies we've tracked spent $1.4 billion in 2013 alone. Here are our top five takeaways from following all that money.





What We've Learned From Four Years of Diving Into Dollars for Docs

David Sleight/ProPublica



by Charles Ornstein, Eric Sagara and Ryann Grochowski Jones, ProPublica




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rnZxYd

FDA: Warning letters hit 5-year low in 2013




The number of warning letters sent by the FDA last year to medical device companies fell for the 1st time since 2009, according to a report from the watchdog agency's Center for Devices & Radiological Health.





FDA: Warning letters hit 5-year low in 2013

Click image to enlarge



The number of warning letters sent by the FDA to medical device companies dipped for the 1st time since 2009, according to a report from the agency's Center for Devices & Radiological Health.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uWtZGK

Fourth time's the charm: pSivida, Alimera jump on FDA nod for Iluvien




Shares of pSivida and Alimera Sciences jump after the FDA approves their Iluvien treatment for diabetic macular edema.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rw4c88

Intuitive Surgical wins FDA nod for new robotic 'wrist'




Intuitive Surgical says the FDA cleared a new robotic 'wrist' for hysterectomies and other procedures for its da Vinci Si device.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vpDO2g

BSX loses $309M judgment in patent war with the family of Dr. Michel Mirowski | Medtech legal news for the week of September 29, 2014




Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific loses $309 million judgment in Mirowski patent war; Ex-Advanced Medical Optics CEO Mazzo indicted in insider trading case; Appeals court denies BD bid to revisit loss to Retractable Technologies; Ackman threatens to sue Allergan again over potential Salix deal; Judge upholds $30M infringement ruling against NuVasive, cancels trademark






Boston Scientific loses $309 million judgment in Mirowski patent war


September 24, 2014 by Brad Perriello




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rw49JA

Appeals court vacates FDA's rescission of ReGen's MenaFlex implant




A federal appeals court vacates the FDA's decision to rescind its 510(k) clearance for ReGen Biologics' MenaFlex knee implant, ordering the watchdog agency to conduct "further proceedings."








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://www.massdevice.com/news/appeals-court-vacates-fdas-rescission-regens-menaflex-implant

Diabetes: Patients hack glucose monitors | MassDevice.com On Call




More and more patients are reportedly hacking into their glucose monitors to add functions like online data display and continuous glucose monitoring.






MassDevice.com On Call


MASSDEVICE ON CALL — More and more patients are hacking into their glucose monitors to add functionality, with medical device companies lagging behind as they work their own improvements through the FDA, according to the Wall Street Journal.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1voKAoX

The last reprogramming




Westby G. Fisher, MD, FACC is a board certified internist, cardiologist, and cardiac electrophysiologist practicing at NorthShore University HealthSystem in Evanston, IL, USA and is a Clinical Associate Professor of Medicine at University of Chicago's Pritzker School of Medicine.





By Westby G. Fisher, MD, FACC


Westby Fisher

He had called the other day to update me up on his condition. He did not sound upset, but resolute. "They offered me peritoneal dialysis," he said, "but I decided against it and figured I'd just let nature take its course. The hospice people are so wonderful - I've got things all set here at home, but I have two questions. What should I do about my warfarin? You know, I just don't want to have a stroke. And what I do about my defibrillator?"



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/YBfaPy

New U.S. tax rules may lead Medtronic to redo inversion deal




Medtronic is likely to attempt a renegotiation of its $43 billion acquisition of Covidien now that the U.S. Treasury Dept. has changed the rules on tax inversion deals.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1taVRVv

divendres, 26 de setembre del 2014

Blood cleansing "biospleen" shows promise against sepsis




Researchers at Harvard's Wyss Institute say they have made progress on a "biospleen," which could combat against sepsis





NEW YORK (Reuters Health) - An extracorporeal blood cleansing device works well in rats and in experiments with human blood, according to researchers in the US and in France.


"Based on our exciting results in rats, we are actively moving to test this approach in a large animal as the next step towards moving this to human clinical trials," Donald E. Ingber of Harvard School of Engineering and Applied Sciences Wyss Institute in Boston told Reuters Health by email.


In a September 14th online paper in Nature Medicine, Dr. Ingber and colleagues explain that infected blood flowing into this "biospleen" is mixed with magnetic nanobeads.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/ZY6iV4

ReFlow Medical wins CE Mark for crossing catheters




ReFlow Medical wins CE Mark approval in the European Union for a pair of crossing catheters, the Wingman35 and Spex devices.






ReFlow Medical said physicians in Germany are already using its Wingman35 and Spex crossing catheters, after the San Clemente, Calif.-based company won CE Mark approval for both devices for treating lesions in the peripheral vasculature.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/ZXntGr

Alcon wins date with FDA panel for AcrySof lens




Alcon Laboratories wins a date with an FDA advisory panel to consider a new indication for its AcrySof IQ ReSTOR intraocular lens.






Alcon Laboratories won a date before an FDA advisory panel in November to review the data behind its application for a new indication for its AcrySof IQ ReSTOR intraocular lens, the watchdog agency said today.


The AcrySof IQ ReSTOR lens is already approved in the U.S. to treat presbyopia and cataracts.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vlFyYz

Silicon Valley Bank's Ben Johnson talks early-stage medtech investment slump | Medtech funding for the week of September 22, 2014




Here's a look at some of the top legal news stories for medical device companies this week: What's behind the slump in early-stage medtech investment?; iHealth realigns, eyes the globe with new $25M investment; Ivantis adds $25M, eyes U.S. approval for glaucoma micro-stent; Minerva Surgical's just an inch away from closing a $25.5M round; Palmaz Scientific uncorks more funding






What's behind the slump in early-stage medtech investment?


September 24, 2014 by Brad Perriello




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qCkRD0

Replace aortic valve in a timely fashion: researchers




Researchers recommend quick surgery for patients with severe symptomatic aortic stenosis





regular_gray495.png

NEW YORK (Reuters Health) - Patients with severe symptomatic aortic stenosis who need aortic valve replacement should have the surgery as soon as possible, new research suggests.


"Our research highlights the importance of treating aortic stenosis in a timely fashion. Delays lead to unnecessary risk and patients should ideally have an aortic valve replacement within a month of diagnosis," Dr. Chris Malaisrie of Northwestern University, Feinberg School of Medicine, in Chicago, Illinois, told Reuters Health by email.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/YisCY1

The pharma trend that should scare the crap out of medical device sales reps




Pharmaceutical companies have slashed sales staffs in favor of key account reps amid a drastic decline in access to physicians.





The pharma trend that should scare the crap out of medical device sales reps

Image courtesy ZS Associates. Click to enlarge





read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1n9zfbl

Sensory processing problems in autism: Mice reveal brain mechanisms, treatment potential




Vector is Children's Hospital Boston's blog about research and innovation in pediatric and adult medicine. We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital.







A mouse study explores how sound and touch information come together in the autistic brain (Image courtesy Nadine Gogolla)

By Parizad Bilimoria




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qBO015

dijous, 25 de setembre del 2014

Volunteers use 3D printers to create inexpensive prosthetics




e-NABLE, an online group of 1,500 volunteers, uses 3D printing to build prosthetics for patients in need.






NEW YORK (Reuters Health) - An online organization of more than 1,500 volunteers is using 3D printers to produce prosthetic hands or fingers for people around the world who need them.


This Sunday, the group, called e-NABLE, will come together at the Johns Hopkins Hospital in Baltimore to further their goals of designing, printing and distributing their inexpensive plastic prostheses, in advance of an upcoming U.S. Food and Drug Administration public forum on 3D printing of medical devices.



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1CoVHR3

Analyst: Boston Scientific could take pacer lead




Despite Boston Scientific having yet to debut a pacemaker that nestles inside the heart itself, an analyst said the company may be best positioned to capitalize on sales of such devices.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1BcqI8c

Nobel Biocare takes patent war to the border




Nobel Biocare escalated its patent battle against Neodent by asking the International Trade Commission to intervene, after Neodent launched a line of dental implants last March that it imports from Brazil.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1BciTQ5

Cook Medical promotes Creissel to urology veep | Personnel Moves




Cook Medical promotes Jean-Marc Creissel to be vice president of its urology business.






Cook Medical said it promoted Jean-Marc Creissel to vice president of its urology business, which Creissel has led since 2010.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rfEDdM

Echo Therapeutics is on the ropes




Echo Therapeutics abruptly suspends operations, saying its cash resources will be drained by the end of the month and raising the possibility of a bankruptcy filing.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Co4ouR

Judge upholds $30M infringement ruling against NuVasive, cancels trademark




A federal judge in California upholds a $30 million trademark infringement judgment against NuVasive and revokes its registrations for the 'neurovision' name.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1reyWwC

Orthofix CFO bails after 6 months amid deepening financial fix




Orthofix International CFO Mark Heggestad steps down after just 6 months as a 3-year financial restatement deepens on new evidence of inventory control problems.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1BbjmBS

TriVascular Tech recall of stent grafts may drag down full-year revenues | Medtech Wall Street news for the week of September 22, 2014




Here's a look at some of the top Wall Street stories for medical device companies this week: TriVascular Tech's stent graft recall could hurt the bottom line; Alere unveils $3.82B privatization plan; Medtronic, Covidien slide on new U.S. inversion rules; Baxano puts itself on the auction block; Philips to carve out lighting biz, merger healthcare & consumer units






TriVascular Tech's stent graft recall could hurt the bottom line


September 19, 2014 by Arezu Sarvestani


TriVascular Tech's stent graft recall could hurt the bottom line



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/ZQIqTq

Zoll, Philips win Defense Dept. contracts




The U.S. Defense Dept. awards rivals Philips Healthcare and Zoll Medical separate contracts to supply airworthy defibrillators.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/ZQIqCO

FDA guides on custom devices




The FDA releases its final recommendations on legal exemptions for customized medical devices.






The FDA yesterday released its final recommendations for legal exemptions for customized medical devices that deviate from already-approved systems by being tailored to the special needs of up to 5 patients.


Examples of such devices might include implantable devices like artificial discs or surgical screws for very tall people or infants that are otherwise unavailable in the correct size.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1mZB5vt

Our T-cells have been hiding something: Another way to kill bacteria




Vector is Children's Hospital Boston's blog about research and innovation in pediatric and adult medicine. We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital.







Listeria bacteria on a plate. The biology of HIV/AIDS suggests T-cells have a hitherto unrecognized way of killing pathogens like these.

By Tom Ulrich


The immune system, despite its immense complexity, really has only a few ways to kill bacteria:



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1v2VMaF

dimecres, 24 de setembre del 2014

U.S. hospitals unprepared to handle Ebola waste




Safety experts warn that U.S. hospitals may not be ready to safely dispose of infectious waste generated by Ebola virus should it spread to American cities.





regular_1280px-ebola_virus_virion.jpg

CHICAGO (Reuters) - U.S. hospitals may be unprepared to safely dispose of the infectious waste generated by any Ebola virus disease patient to arrive unannounced in the country, potentially putting the wider community at risk, biosafety experts said.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1u0yRfS

Ex-Advanced Medical Optics CEO Mazzo indicted in insider trading case




A grand jury indicts former Advanced Medical Optics CEO James Mazzo in an insider trading case, charging Mazzo with leaking news of Abbott's 2009 buyout of AMO.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1veJUS4

Boston Scientific loses $309 million judgment in Mirowski patent war




Boston Scientific loses a $309 million judgment in its long-running patent war with Mirowski Family ventures over cardiac pacemaker technology.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1v1kQ1M

Your medical record is worth more to hackers than your credit card




Security experts say cyber criminals are increasingly targeting the $3 trillion U.S. healthcare industry, which has many companies still reliant on aging computer systems that do not use the latest security features.





Hostital hackers steal 5 years of patient records

NEW YORK/BOSTON (Reuters) - Your medical information is worth 10 times more than your credit card number on the black market.


Last month, the FBI warned healthcare providers to guard against cyber attacks after one of the largest U.S. hospital operators, Community Health Systems Inc, said Chinese hackers had broken into its computer network and stolen the personal information of 4.5 million patients.



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xhOcLz

Ackman threatens to sue Allergan again over potential Salix deal




Billionaire William Ackman's Pershing Square Capital Management threatens to sue Allergan if it goes ahead with a deal to buy drugmaker Salix Pharmaceuticals.






(Reuters) - Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1B7IOs0

What's behind the slump in early-stage medtech investment?




Blame the medical device tax and the U.S. regulatory environment for the slump in investment in early-stage medical technologies, Silicon Valley Bank's Ben Johnson tells MassDevice.com.






It's a hard world out there for those looking to turn their cutting edge medical device ideas into commercial products, with investors shying away from early-stage companies in favor of more established medtech enterprises.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vcjzEb

FDA releases August 2014 510(k) clearances




The Food & Drug Administration releases data on 510(k) clearances for medical devices it approved in August 2014.





FDA logo

August 2014 510(k) Clearances


510(k) summaries or 510(k) statements for final decisions rendered during the period August 2014.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1r9ULxp

Vital Therapies taps the market for $46M more




Vital Therapies raises another $46 million in a public stock offering as it works on its liver regeneration technology.






Vital Therapies (NSDQ:VTL) raised $46 million in a public offering of stock for its technique for the regeneration of liver tissue.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1mSWHcG

Palmaz Scientific uncorks more funding




Palmaz Scientific, founded by stent pioneer Dr. Julio Palmaz, raises another $1.3 million for the prosthetic implant technology it's developing.






Palmaz Scientific recorded $1.3 million of a planned $4.2 million funding round for the prosthetic implant technology it's developing in Dallas.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://www.massdevice.com/news/palmaz-scientific-uncorks-more-funding

New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy




New U.S. Treasury rules on inversion deals are unlikely to scuttle Medtronic's pending $43 billion merger with Covidien, analysts say, but are likely to make it more complicated and expensive.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xg2BrR

TAVI: Boston Scientific launches U.S. Lotus valve trial




Boston Scientific launches a U.S. clinical trial of its Lotus transcatheter aortic valve implant in high-and extreme-risk patients.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xfMsm6

T2 Biosystems jumps on FDA nod for sepsis tests




Shares of T2 Biosystems jump nearly 10% after the FDA approves its MR-based tests designed to detect sepsis in a matter of hours rather than days.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1mRUgap

FDA seeks public input on medtech hacking | MassDevice.com On Call




FDA regulators and Dept. of Homeland Security officials are co-hosting a public meeting to discuss cybersecurity in medical devices.






MassDevice.com On Call


MASSDEVICE ON CALL — The FDA announced that it will hold a public meeting in October to discuss cybersecurity in medical devices.


Co-hosted with the Dept. of Homeland Security, the 2-day summit will bring together a variety of healthcare stakeholders to discuss areas of vulnerability and best approaches to shoring up the digital defenses of medical systems.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1soX6pu